Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Mader

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|February 7, 2001
Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequenceR Sedivy, B Wolf, M Kalipciyan, et al.
Oncology Research|January 1, 1996
Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidineG Findenig, R M Mader, M Fritzer-Szekeres, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Benefit of interferon-alpha2b in a patient with unresectable hepatoma and chronic infection with hepatitis C virusG J Locker, R M Mader, B Steiner, et al.
British Journal of Clinical Pharmacology|September 1, 1995
Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancerR M Mader, G G Steger, B Rizovski, et al.
Breast Cancer Research and Treatment|August 10, 2000
Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patientsM Müller, J Bockenheimer, U Zellenberg, et al.
Electrophoresis|December 31, 1998
Analysis of microdialysates from cancer patients by capillary electrophoresisR M Mader, M Brunner, B Rizovski, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 18, 2014
Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapyW Haslik, S Hacker, F X Felberbauer, et al.
Experimental Cell Research|September 21, 2010
Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620I K Tentes, W M Schmidt, G Krupitza, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancerR M Mader, H Zilg, O Schlappack, et al.
Breast Cancer Research and Treatment|June 1, 1995
Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?G J Locker, I Simonitsch, R M Mader, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|February 7, 2001
Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequenceR Sedivy, B Wolf, M Kalipciyan, et al.
Oncology Research|January 1, 1996
Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidineG Findenig, R M Mader, M Fritzer-Szekeres, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Benefit of interferon-alpha2b in a patient with unresectable hepatoma and chronic infection with hepatitis C virusG J Locker, R M Mader, B Steiner, et al.
British Journal of Clinical Pharmacology|September 1, 1995
Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancerR M Mader, G G Steger, B Rizovski, et al.
Breast Cancer Research and Treatment|August 10, 2000
Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patientsM Müller, J Bockenheimer, U Zellenberg, et al.
Electrophoresis|December 31, 1998
Analysis of microdialysates from cancer patients by capillary electrophoresisR M Mader, M Brunner, B Rizovski, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 18, 2014
Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapyW Haslik, S Hacker, F X Felberbauer, et al.
Experimental Cell Research|September 21, 2010
Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620I K Tentes, W M Schmidt, G Krupitza, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancerR M Mader, H Zilg, O Schlappack, et al.
Breast Cancer Research and Treatment|June 1, 1995
Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?G J Locker, I Simonitsch, R M Mader, et al.
Pageof 5